LNWWM
RMD icon

Laird Norton Wetherby Wealth Management’s ResMed RMD Stock Holding History

Laird Norton Wetherby Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$810K Buy
2,959
+99
+3% +$27K 0.03% 433
2025
Q2 		$738K Buy
+2,860
New +$682K 0.03% 449
2024
Q4 		$761K Sell
3,326
-270
-8% -$65K 0.04% 408
2024
Q3 		$878K Sell
3,596
-109
-3% -$24.4K 0.04% 388
2024
Q2 		$709K Sell
3,705
-61
-2% -$12.4K 0.03% 433
2024
Q1 		$746K Buy
3,766
+27
+0.7% +$4.95K 0.04% 431
2023
Q4 		$643K Buy
3,739
+1,523
+69% +$234K 0.03% 457
2023
Q3 		$328K Sell
2,216
-190
-8% -$34.4K 0.02% 661
2023
Q2 		$526K Sell
2,406
-467
-16% -$104K 0.03% 519
2023
Q1 		$629K Buy
2,873
+22
+0.8% +$4.77K 0.04% 458
2022
Q4 		$593K Sell
2,851
-497
-15% -$109K 0.04% 467
2022
Q3 		$731K Buy
3,348
+562
+20% +$128K 0.05% 360
2022
Q2 		$584K Buy
2,786
+292
+12% +$62.2K 0.04% 453
2022
Q1 		$605K Buy
2,494
+147
+6% +$35.6K 0.03% 455
2021
Q4 		$611K Buy
2,347
+36
+2% +$9.34K 0.03% 454
2021
Q3 		$609K Buy
2,311
+25
+1% +$6.84K 0.04% 441
2021
Q2 		$564K Buy
2,286
+22
+1% +$4.63K 0.03% 471
2021
Q1 		$439K Sell
2,264
-61
-3% -$12.2K 0.03% 478
2020
Q4 		$494K Sell
2,325
-24
-1% -$4.79K 0.03% 466
2020
Q3 		$403K Buy
2,349
+8
+0.3% +$1.48K 0.04% 428
2020
Q2 		$449K Sell
2,341
-173
-7% -$28.3K 0.04% 384
2020
Q1 		$370K Buy
2,514
+425
+20% +$67.7K 0.04% 393
2019
Q4 		$324K Buy
2,089
+48
+2% +$6.92K 0.03% 515
2019
Q3 		$276K Buy
2,041
+310
+18% +$40.6K 0.03% 570
2019
Q2 		$211K Buy
+1,731
New +$192K 0.02% 633

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Laird Norton Wetherby Wealth Management's RMD Position: Q3 2025 in Review

Laird Norton Wetherby Wealth Management increased its ResMed (RMD) stake by 3.5% in Q3 2025, buying an estimated $27K and bringing the position to 2,959 shares worth $810K. The position accounts for 0.03% of the portfolio, ranked #433.

Laird Norton Wetherby Wealth Management first reported a position in RMD in Q2 2019 and has held it in 25 quarters since. The position peaked at $878K in Q3 2024. 949 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Laird Norton Wetherby Wealth Management held 2,959 shares of ResMed worth $810K as of Q3 2025.
  • Laird Norton Wetherby Wealth Management bought 99 ResMed shares in Q3 2025, an estimated $27K.
  • ResMed made up 0.03% of Laird Norton Wetherby Wealth Management's portfolio in Q3 2025, its #433 holding.
  • Laird Norton Wetherby Wealth Management first reported a position in ResMed in Q2 2019 and has held it in 25 quarters since.
  • Laird Norton Wetherby Wealth Management's ResMed position peaked at $878K in Q3 2024.
  • 949 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Laird Norton Wetherby Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.